• Home
• Logistical Information
• Agenda
• Event Registration
• Poster Submission
• Contact Information

Welcome

General Information

The National Cancer Institute (NCI) has made a strong commitment to supporting the development and application of novel and potentially paradigm-shifting technologies in the Nation's continuing battle against cancer. Since 1999, the Innovative Molecular Analysis Technologies (IMAT, http://innovation.cancer.gov) program has been a central part of this effort, supporting innovative and emerging technologies of interest for cancer research and cancer medicine.We are very pleased to invite you to participate in NCI's Tenth Principal Investigators (PI) Meeting for the IMAT program to be held on October 7-9, 2009, at the Hyatt Regency Bethesda in Bethesda, Maryland.

Owing to last year's success, we are excited to let you know that this year's meeting will be held again in conjunction with NCI's Clinical Proteomics Technologies Initiative for Cancer (CPTC) meeting. There will be a joint session on the morning of Wednesday, October 7, followed by a joint networking and poster session. For more information on the CPTC meeting, please go to: http://www.capconcorp.com/meeting/proteomic2009/.

To view last year’s meeting agenda, click here.

Description

The intent of the IMAT PI meeting is to provide the opportunity for participants in this program to share their ideas and progress in an open forum with investigators representing a broad range of scientific expertise. In addition, we would like to use this opportunity to share information with you on complementary NCI programs and NCI research resources as well as to solicit your ideas on how the NCI can accelerate your progress in developing new molecular analysis technologies for cancer research.

In accordance with guidelines in the grant, all PIs are expected to personally participate in the meeting utilizing the budgetary resources allocated for travel in their original IMAT applications. In the unfortunate event that previous commitments preclude your attendance, we would recommend the attendance of an appropriate senior member of your research team. We appreciate that for some projects critical direction is also being provided by a co-PI, and will consider requests for the attendance of this investigator as a second representative of the project at the meeting. These requests should be addressed to Mark Lim, Ph.D., at limm2@mail.nih.gov or (301) 443-7446. In general, we are limiting attendance to the PI on the award.

For each funded project, the PI should submit an abstract for poster presentation. A limited number of projects will be selected for oral presentation at the meeting on the basis of the abstracts. We appreciate that some of the projects have only recently been awarded, and recommend that posters for these projects, in lieu of limited preliminary data, focus on the technology proposed and plans for the future.